UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Development of interim patient‐reported outcome measures for the assessment of ulcerative colitis disease activity in clinical trials

Alimentary pharmacology & therapeutics, 2015-11, Vol.42 (10), p.1200-1210

2015

Volltextzugriff (PDF)

A retrospective analysis: the development of patient reported outcome measures for the assessment of Crohn's disease activity

Alimentary pharmacology & therapeutics, 2015-01, Vol.41 (1), p.77-86

2015

Volltextzugriff (PDF)

Review article: dose optimisation of infliximab for acute severe ulcerative colitis

Alimentary pharmacology & therapeutics, 2017-03, Vol.45 (5), p.617-630

2017

Volltextzugriff (PDF)

A prospective cohort study to determine the relationship between serum infliximab concentration and efficacy in patients with luminal Crohn's disease

Alimentary pharmacology & therapeutics, 2014-05, Vol.39 (10), p.1126-1135

2014

Volltextzugriff (PDF)

IOIBD technical review on endoscopic indices for Crohn's disease clinical trials

Gut, 2016-09, Vol.65 (9), p.1447-1455

2016

Volltextzugriff (PDF)

Validated gene expression biomarker analysis for biopsy‐based clinical trials in ulcerative colitis

Alimentary pharmacology & therapeutics, 2014-09, Vol.40 (5), p.477-485

2014

Volltextzugriff (PDF)

The development of a magnetic resonance imaging index for fistulising Crohn's disease

Alimentary pharmacology & therapeutics, 2017-09, Vol.46 (5), p.516-528

2017

Volltextzugriff (PDF)

Review article: pharmacological aspects of anti‐TNF biosimilars in inflammatory bowel diseases

Alimentary pharmacology & therapeutics, 2015-11, Vol.42 (10), p.1158-1169

2015

Volltextzugriff (PDF)

Randomised clinical trial: a phase 1, dose‐ranging study of the anti‐matrix metalloproteinase‐9 monoclonal antibody GS‐5745 versus placebo for ulcerative colitis

Alimentary pharmacology & therapeutics, 2016-07, Vol.44 (2), p.157-169

2016

Volltextzugriff (PDF)

Systematic review with meta‐analysis: placebo rates in induction and maintenance trials of Crohn's disease

Alimentary pharmacology & therapeutics, 2017-04, Vol.45 (8), p.1021-1042

2017

Volltextzugriff (PDF)

Editorial: drug monitoring targets for optimising adalimumab in Crohn's disease

Alimentary pharmacology & therapeutics, 2014-10, Vol.40 (7), p.854-855

2014

Volltextzugriff (PDF)

Letter: limitations of studies to evaluate the significance of anti‐tumour necrosis factor serum levels in Crohn's disease – authors' reply

Alimentary pharmacology & therapeutics, 2014-07, Vol.40 (1), p.121-122

2014

Volltextzugriff (PDF)

P059 GB004 drives protective effects on immune cells and epithelial cells using human ex vivo monolayer and co-culture systems

Journal of Crohn's and colitis, 2021-05, Vol.15 (Supplement_1), p.S165-S166

2021

Volltextzugriff (PDF)

DOP74 Artificial Intelligence Quantifying Endoscopic Severity of Ulcerative Colitis in Gradation Scale

Journal of Crohn's and colitis, 2023-01, Vol.17 (Supplement_1), p.i151-i152

2023

Volltextzugriff (PDF)

Performance of Crohn's disease Clinical Trial Endpoints based upon Different Cutoffs for Patient Reported Outcomes or Endoscopic Activity: Analysis of EXTEND Data

Inflammatory bowel diseases, 2018-04, Vol.24 (5), p.932-942

2018

Volltextzugriff (PDF)

DOP05 Target engagement and pharmacodynamic biomarker analysis following treatment with the oral gut-targeted HIF-1α stabilizer GB004 in a Phase 1b trial in Active Ulcerative Colitis

Journal of Crohn's and colitis, 2021-05, Vol.15 (Supplement_1), p.S043-S043

2021

Volltextzugriff (PDF)

Vedolizumab for the Treatment of Moderately to Severely Active Ulcerative Colitis

Pharmacotherapy, 2015-10, Vol.35 (10), p.979-979

2015

Volltextzugriff (PDF)

P544 Histological remission following ozanimod treatment is associated with concurrent clinical remission and endoscopic mucosal healing: Results from the TOUCHSTONE study

Journal of Crohn's and colitis, 2018-01, Vol.12 (supplement_1), p.S381-S381

2018

Volltextzugriff (PDF)

Central Endoscopy Reading in Inflammatory Bowel Diseases

Journal of Crohn's and colitis, 2016-09, Vol.10 (suppl_2), p.S542-S547

2016

Volltextzugriff (PDF)

HIV testing among young adults and older adolescents in the setting of acute substance abuse treatment

Journal of acquired immune deficiency syndromes (1999), 2001-06, Vol.27 (2), p.135-142

2001

Volltextzugriff (PDF)

Initiating Azathioprine for Crohn's Disease

Clinical gastroenterology and hepatology, 2012-05, Vol.10 (5), p.460-465

2012

Volltextzugriff (PDF)

HIV Risk Behaviors in Adolescent and Young Adult Substance Users Undergoing Treatment

Journal of HIV/AIDS prevention & education for adolescents & children, 2001, Vol.4 (4), p.43-54

2001

Volltextzugriff (PDF)

Can we predict ectotherm responses to climate change using thermal performance curves and body temperatures?

Ecology letters, 2016-11, Vol.19 (11), p.1372-1385

2016

Volltextzugriff (PDF)

Treat to Target: A Proposed New Paradigm for the Management of Crohn's Disease

Clinical gastroenterology and hepatology, 2015-06, Vol.13 (6), p.1042-1050.e2

2015

Volltextzugriff (PDF)

A global consensus on the classification, diagnosis and multidisciplinary treatment of perianal fistulising Crohn's disease

Gut, 2014-09, Vol.63 (9), p.1381-1392

2014

Volltextzugriff (PDF)

1 – 25 von 356

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(330)
Mit Volltextzugriff
(296)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(237)
Life Sciences & Biomedicine
(185)
Humans
(149)
Female
(99)
Male
(92)
Middle Aged
(65)
Adult
(55)
Biological And Medical Sciences
(49)
Animals
(44)
Aged
(41)
Physical Sciences
(38)
Medical Sciences
(36)
Treatment Outcome
(27)
Gastroenterology & Hepatology
(24)
Life Sciences
(23)
Mice
(23)
Neurosciences & Neurology
(20)
Radiology, Nuclear Medicine & Medical Imaging
(18)
Science & Technology - Other Topics
(18)
Adolescent
(17)

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

MEDLINE
(188)
Journals@Ovid
(159)
IngentaConnect
(153)
EZB Electronic Journals Library
(150)
Elsevier ScienceDirect Journals Complete
(97)
Standalone journals
(83)
Wiley Online Library Journals
(59)
Elsevier Journal Backfiles on ScienceDirect (DFG Nationallizenzen)
(59)
IngentaConnect Journals
(51)
Wiley Online Library
(47)
JSTOR
(32)
Oxford journals
(25)
Oxford Journals 2020 Medicine
(23)
Springer Nature - Connect here FIRST to enable access
(19)
Nexis Uni
(14)
SpringerLink_现刊
(12)
Taylor & Francis Online
(11)
Taylor & Francis
(10)
Taylor & Francis Journals
(9)
BMJ Journals
(8)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Development of interim patient‐reported outcome measures for the assessment of ulcerative colitis disease activity in clinical trials

A retrospective analysis: the development of patient reported outcome measures for the assessment of Crohn's disease activity

Review article: dose optimisation of infliximab for acute severe ulcerative colitis

A prospective cohort study to determine the relationship between serum infliximab concentration and efficacy in patients with luminal Crohn's disease

IOIBD technical review on endoscopic indices for Crohn's disease clinical trials

Validated gene expression biomarker analysis for biopsy‐based clinical trials in ulcerative colitis

The development of a magnetic resonance imaging index for fistulising Crohn's disease

Review article: pharmacological aspects of anti‐TNF biosimilars in inflammatory bowel diseases

Randomised clinical trial: a phase 1, dose‐ranging study of the anti‐matrix metalloproteinase‐9 monoclonal antibody GS‐5745 versus placebo for ulcerative colitis

Systematic review with meta‐analysis: placebo rates in induction and maintenance trials of Crohn's disease

Editorial: drug monitoring targets for optimising adalimumab in Crohn's disease

Letter: limitations of studies to evaluate the significance of anti‐tumour necrosis factor serum levels in Crohn's disease – authors' reply

P059 GB004 drives protective effects on immune cells and epithelial cells using human ex vivo monolayer and co-culture systems

DOP74 Artificial Intelligence Quantifying Endoscopic Severity of Ulcerative Colitis in Gradation Scale

Performance of Crohn's disease Clinical Trial Endpoints based upon Different Cutoffs for Patient Reported Outcomes or Endoscopic Activity: Analysis of EXTEND Data

DOP05 Target engagement and pharmacodynamic biomarker analysis following treatment with the oral gut-targeted HIF-1α stabilizer GB004 in a Phase 1b trial in Active Ulcerative Colitis

Vedolizumab for the Treatment of Moderately to Severely Active Ulcerative Colitis

P544 Histological remission following ozanimod treatment is associated with concurrent clinical remission and endoscopic mucosal healing: Results from the TOUCHSTONE study

Central Endoscopy Reading in Inflammatory Bowel Diseases

HIV testing among young adults and older adolescents in the setting of acute substance abuse treatment

Initiating Azathioprine for Crohn's Disease

HIV Risk Behaviors in Adolescent and Young Adult Substance Users Undergoing Treatment

Can we predict ectotherm responses to climate change using thermal performance curves and body temperatures?

Treat to Target: A Proposed New Paradigm for the Management of Crohn's Disease

A global consensus on the classification, diagnosis and multidisciplinary treatment of perianal fistulising Crohn's disease

Suchergebnisse filtern